ADMA Biologics makes immune globulin treatments from human blood plasma for patients with weakened immune systems. It last closed at $13.17 on Nov 20, down 1.27% on the day. The next earnings report for ADMA is expected around Mon, Jan 11, 2027. For the quarter ended Sep 2026, ADMA reported EPS of $0.22 on revenue of $141.1M, with revenue up 5.1% from a year ago. Over its last 8 reports the stock moved an average of 10.3% the session after earnings. Over the last 12 months ADMA insiders bought $468K of stock on the open market and sold $3.4M, according to SEC Form 4 filings.
AI Auto Pilots
Is ADMA in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold ADMA.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on ADMAStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
ADMA · as of the Nov 20 close · updated each morning
Uptrend, nearing overbought
The stock is 6% above its 20 day and 17% above its 50 day average. It is 19% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 62), near overbought. The nearest support is the Pivot S1 at $13.02, and the nearest resistance the Pivot at $13.25.
Short trendBullish
Long trendBullish
MomentumStrong
StretchNear overbought
VolatilityHigh, 4.7%/day
Key levels
$20.4652 week high+55.4%
$13.77Swing high (Nov 5)+4.6%
$13.39Pivot R1+1.7%
$13.25Pivot+0.6%
$13.17Last close
$13.02Pivot S1−1.1%
$12.4020 day average−5.8%
$10.9750 day average−16.7%
$10.64200 day average−19.2%
$10.57Swing low (Oct 23)−19.7%
$10.10100 day average−23.3%
$7.2152 week low−45.3%
Indicators
RSI (14)
62.14
Strong, overbought above 70
Neutral
MACD
0.75
Above its signal line
Bullish
Stochastic
78.7
Middle of its range
Neutral
ADX (14)
37.0
Trending up
Williams %R
-26.1
Oversold below −80, overbought above −20
Neutral
CCI (20)
57.4
Oversold below −100, overbought above 100
Neutral
Rate of change
+3.5%
Change over 10 sessions
Bullish
ATR (14)
$0.62
Typical daily range, 4.7% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Above
MA 200Above
Uptrend, nearing overbought
Short trendBullish
Long trendBullish
MomentumStrong
StretchNear overbought
VolatilityNormal, 9.0%/day
Key levels
$20.4652 week high+55.4%
$13.77Swing high (Nov 5)+4.6%
$13.39Pivot R1+1.7%
$13.25Pivot+0.6%
$13.17Last close
$13.02Pivot S1−1.1%
$12.4020 day average−5.8%
$10.9750 day average−16.7%
$10.64200 day average−19.2%
$10.57Swing low (Oct 23)−19.7%
$10.10100 day average−23.3%
$7.2152 week low−45.3%
Indicators
RSI (14)
66.12
Strong, overbought above 70
Neutral
MACD
0.46
Above its signal line
Bullish
Stochastic
85.3
Near the top of its range
Overbought
ADX (14)
27.6
Trending up
Williams %R
-18.2
Oversold below −80, overbought above −20
Overbought
CCI (20)
201.1
Oversold below −100, overbought above 100
Overbought
Rate of change
+42.7%
Change over 10 sessions
Bullish
ATR (14)
$1.19
Typical daily range, 9.0% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Below
MA 200Above
What happened before, for ADMA
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how ADMA did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow ADMA usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for ADMAHow many large options trades hit ADMA, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in ADMA in the last 90 days.
From SEC Form 4 filings by ADMA's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ADMA is in one of them and how their past ADMA trades turned out.
ADMA Biologics is a biopharmaceutical company based in Ramsey, New Jersey. It makes specialty biologics from human blood plasma for people with weakened immune systems and for people at risk of certain infectious diseases. Its main products are ASCENIV and BIVIGAM, two immune globulin treatments for primary immunodeficiency, and Nabi-HB, which is used after exposure to hepatitis B. The company also operates plasma collection centers, sells some plasma to other manufacturers, and its products are mainly used by physician specialists.